# BioNTech SE: Form 6-K, filed Aug 16, 2024

- Company: [BioNTech SE](/companies/bntx.md) (CIK 1776985)
- Form: 6-K
- Filed: 2024-08-16
- Accepted by EDGAR: Aug 16, 2024, 06:56 ET
- Period: 2024-08-16
- Accession: 0001776985-24-000073
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1776985/000177698524000073/form6-kcombovaccineph23upd.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1776985/000177698524000073/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1776985/000177698524000073/form6-kcombovaccineph23upd.htm

Filed Aug 16, 2024.
Source: SEC EDGAR, the filing index for accession 0001776985-24-000073. Last ingested by Listed: Nov 10, 2026, 16:47 ET. No prices; not investment advice.
